Papers

1

Total Citations

3

H-Index

1

About

Dr. Muhu Tang is a leading figure in thoracic surgical oncology, with a focused expertise in the minimally invasive management of esophageal cancer. His work critically evaluates the comparative effectiveness of modern surgical techniques, particularly in patients undergoing neoadjuvant therapy. Dr. Tang’s most cited study, a 2024 retrospective analysis, provides a pivotal three-way comparison of robot-assisted esophagectomy (RAE), video-assisted minimally invasive esophagectomy (VAMIE), and traditional open esophagectomy (OE). This research directly addresses a key clinical question by assessing the short-term safety and efficacy of these approaches, offering crucial data to guide surgical decision-making in a complex patient population. By systematically analyzing outcomes following neoadjuvant treatment, his work helps define the optimal role for robotic and video-assisted platforms in improving recovery and reducing complications. With his 2024 paper already garnering early citations, Dr. Tang is establishing himself as a key voice in the evidence-based evolution of esophageal cancer surgery, pushing the field toward less invasive, yet equally effective, standards of care.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Comparisons of short-term outcomes between robot-assisted, video-assisted, and open esophagectomy for resectable esophageal cancer after neoadjuvant treatment: a retrospective study
3 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: First Affiliated Hospital Zhejiang University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago